NF-κB was found to be overexpressed in CCA tissues and the inhibition of NF-κB action significantly enhanced cell apoptosis and reduced cell growth, which suggests NF-κB as a potential molecular target for CCA therapy [68]. The gene discussed is NFKB1; the disease is cholangiocarcinoma.